Effectiveness of Fentanyl-Added TAP Block in Laparoscopic Cholecystectomy

Launched by ULUDAG UNIVERSITY · Jan 12, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at how effective it is to add fentanyl, a pain-relieving medication, to a local anesthetic technique called the TAP block for patients undergoing laparoscopic cholecystectomy, which is a minimally invasive surgery to remove the gallbladder. The goal is to see if combining fentanyl with the TAP block can improve pain management after surgery compared to using the TAP block with just bupivacaine, another local anesthetic.

To be eligible for this trial, participants should be between 18 and 70 years old and scheduled for this type of surgery. They should also be in good general health, as defined by a standard classification system. However, individuals who are pregnant, have certain medical conditions, or are significantly overweight will not be included. If you participate, you can expect to receive one of the two treatment methods to help manage your pain after surgery, and the study will compare the results to determine which method works better.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients aged 18 to 70 years
• • American Society of Anesthesiologists (ASA) classification I-II-III according to the American Society of Anesthesiologists
• • Patients who provide written informed consent
• • Patients scheduled for elective laparoscopic cholecystectomy
• Exclusion Criteria:
• • Pregnancy or suspected pregnancy
• • BMI \> 35
• • Known allergy to local anesthetics or opioids
• • Suspected coagulopathy or infection at the injection site
• • Severe neurological, psychiatric, cardiovascular, liver, or renal failure
• • Patients converted to open surgery intraoperatively